文献速递妇科肿瘤

外观局限于卵巢的1-2级子宫内膜样卵巢癌淋巴结分期是否值得

Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
PubMed 文献 · Eur J Cancer · 2023-10-20

这项多中心回顾性观察队列研究纳入1985年5月至2019年12月手术的298例pT1 N0/N1/Nx、1-2级子宫内膜样卵巢癌患者,评估淋巴结清扫与无病生存(DFS)和总生存(OS)的关系。中位随访45个月,全队列5年DFS和OS分别为89.8%和96.2%;淋巴结清扫组5年DFS和OS优于未清扫组(92.0% vs 85.6%,p=0.016;97.7% vs 92.8%,p=0.013),2级患者中该差异仍存在。

要点

  • 298例1-2级子宫内膜样卵巢癌中199例(66.8%)接受淋巴结评估,11例(5.5%)病理淋巴结阳性(FIGO IIIA1)。
  • 中位随访45个月,全队列5年DFS为89.8%,5年OS为96.2%。
  • 淋巴结清扫组5年DFS和OS优于未清扫组(92.0% vs 85.6%,p=0.016;97.7% vs 92.8%,p=0.013)。

核心结论

  • 2级子宫内膜样卵巢癌患者行分期淋巴结清扫与DFS和OS改善相关。
  • 1级与2级可能被视为两种不同实体,在外科分期方面可能受益于不同处理方式。
  • 作者认为需要纳入分子特征的前瞻性研究来确认这一罕见情形中的生存驱动因素。

研究设计与样本

  • 多中心、回顾性、观察性队列研究。
  • 纳入1985年5月至2019年12月手术、pT1 N0/N1/Nx、1-2级子宫内膜样卵巢癌患者,共298例。
  • 按是否行淋巴结清扫(切除任何淋巴结 vs 未行淋巴结评估)分层,并按肿瘤分级进行亚组分析。
  • 采用Kaplan-Meier曲线和Cox回归进行生存分析。

主要发现

  • 199例(66.8%)接受淋巴结评估,其中166例(83.4%)行单侧/双侧盆腔及腹主动脉旁/腔静脉旁淋巴结清扫。
  • 接受淋巴结评估者中11例(5.5%)显示病理转移淋巴结(FIGO IIIA1)。
  • 27例(9.1%)合并同步子宫内膜样子宫内膜癌。
  • 中位随访45个月(95%CI:37.5-52.5),全队列5年DFS为89.8%,5年OS为96.2%。
  • 年龄≤51岁(HR=0.24,95%CI:0.06-0.91;p=0.036)和行淋巴结清扫(HR=0.25,95%CI:0.07-0.82;p=0.022)是死亡风险的独立保护因素。

临床怎么用

  • 原文结论指出,2级子宫内膜样卵巢癌患者行分期淋巴结清扫与DFS和OS改善相关。
  • 原文结论提出,1级与2级可能被视为两种不同实体,在外科分期方面可能受益于不同处理方式。
  • 原文未据此给出推荐。

局限性

  • 原文结论指出需要纳入分子特征的前瞻性研究来确认这一罕见情形中的生存驱动因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to assess the disease-free survival (DFS) and overall survival (OS) of patients with grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary, according to surgical staging. METHODS: Multicenter, retrospective, observational cohort study. Patients with endometrioid ovarian carcinoma, surgical procedure performed between May 1985 and December 2019, stage pT1 N0/N1/Nx, grade 1-2 were included. Patients were stratified according to lymphadenectomy (defined as removal of any lymph node versus no lymph node assessment), and subgroup analyses according to tumor grade were performed. Kaplan-Meier curves and cox regression analyses were used to perform survival analyses. RESULTS: 298 patients were included. 199 (66.8 %) patients underwent lymph node assessment. Of these, 166 (83.4 %) had unilateral/bilateral pelvic and para-aortic/caval lymphadenectomy. Eleven (5.5 %) patients of those who underwent lymph node assessment showed pathologic metastatic lymph nodes (FIGO stage IIIA1). Twenty-seven patients (9.1 %) had synchronous endometrioid endometrial cancer. After a median follow up of 45 months (95 %CI:37.5-52.5), 5-year DFS and OS of the entire cohort were 89.8 % and 96.2 %, respectively. Age ≤ 51 years (HR=0.24, 95 %CI:0.06-0.91; p = 0.036) and performance of lymphadenectomy (HR=0.25, 95 %CI: 0.07-0.82; p = 0.022) represented independent protective factors toward risk of death. Patients undergoing lymphadenectomy had better 5-year DFS and OS compared to those not receiving lymphadenectomy, 92.0 % versus 85.6 % (p = 0.016) and 97.7 % versus 92.8 % (p = 0.013), respectively. This result was confirmed after exclusion of node-positive patients. When stratifying according to tumor grade (node-positive excluded), patients with grade 2 who underwent lymphadenectomy had better 5-year DFS and OS than those without lymphadenectomy (93.0 % versus 83.1 %, p = 0.040 % and 96.5 % versus 90.6 %, p = 0.037, respectively). CONCLUSION: Staging lymphadenectomy in grade 2 endometrioid ovarian carcinoma patients was associated with improved DFS and OS. Grade 1 and grade 2 might be considered as two different entities, which could benefit from different approach in terms of surgical staging. Prospective studies, including molecular profiles are needed to confirm the survival drivers in this rare setting.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Bizzarri N, Imterat M, Fruscio R, et al. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth? Eur J Cancer. 2023. PMID: 37890354. doi:10.1016/j.ejca.2023.113398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。